Optiver Holding B.V. Trevi Therapeutics, Inc. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 888 shares of TRVI stock, worth $10,753. This represents 0.0% of its overall portfolio holdings.
Number of Shares
888Holding current value
$10,753% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TRVI
# of Institutions
180Shares Held
113MCall Options Held
1.07MPut Options Held
425K-
Nea Management Company, LLC Timonium, MD13.2MShares$160 Million6.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.3MShares$124 Million2.96% of portfolio
-
Rubric Capital Management LP New York, NY8.53MShares$103 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.83MShares$70.6 Million0.0% of portfolio
-
Marshall Wace, LLP London, X04.84MShares$58.6 Million0.05% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $706M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...